Daewoong pharmaceutical

069620.KO

79.40 USD

-2.10

-2.58%

Overview

Last close

79.40 usd

Market cap

913.60M usd

52 week high

119.39 usd

52 week low

72.15 usd

Target price

139.04 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

0.9422

Price/Book Value

1.6869

Enterprise Value

1.27B usd

EV/Revenue

1.3168

EV/EBITDA

16.65

Key financials

Revenue TTM

967.90M usd

Gross Profit TTM

498.83M usd

EBITDA TTM

132.13M usd

Earnings per Share

N/A usd

Dividend

0.41 usd

Total assets

1.34B usd

Net debt

368.41M usd

About

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.